Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response - Concepedia

Concepedia

Publication | Open Access

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response

DOI Full Paper Access

69

Citations

40

References

2022

Year

Fabio Scirocchi, Simone Scagnoli, Andrea Botticelli, Alessandra Di Filippo, Chiara Napoletano, Ilaria Grazia Zizzari, Lidia Strigari, Enrico Cortesi, Aurelia Rughetti, Paolo Marchetti,

References

	Year	Citations

Page 1